MNDR Mobile-health Network Solutions
Services-Prepackaged Software · Nasdaq · SEC CIK 1976695 · Fiscal year ends 06/30
Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY1.2%
TTM net income YoY5.8%
TTM EPS YoY74.2%
Revenue 3-yr CAGR-0.6%
Net income 3-yr CAGR—
Margins
Gross margin21.2%
Operating margin—
Net margin-41.2%
FCF margin-19.7%
EBITDA margin—
Returns
ROE-51.0%
ROA-40.3%
ROIC (approx.)—
Asset turnover0.98x
Leverage & solvency
Liabilities / assets13.0%
Debt / equity0.00x
Current ratio3.97x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.48x
Accruals ratio-21.0%
Payout ratio—
Capex / revenue0.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $7.74M | $7.65M | $13.97M | $7.87M | $6.99M |
| Cost of revenue | $6.10M | $6.37M | $11.43M | $6.78M | $5.05M |
| Gross profit | $1.64M | $1.28M | $2.54M | $1.09M | $1.94M |
| SG&A expense | $2.02M | $2.67M | $4.93M | $1.90M | $615,473 |
| Pretax income | -$3.19M | -$3.38M | -$15.62M | -$3.21M | $258,472 |
| Income tax | — | — | -$19,194 | — | $165,775 |
| Net income | -$3.19M | -$3.38M | -$15.60M | -$3.21M | $92,697 |
| EPS (basic) | -5.03 | -19.50 | -108.57 | -5.04 | 0.01 |
| EPS (diluted) | -5.03 | -19.50 | -108.57 | -5.04 | 0.01 |
| Weighted avg. shares (diluted) | 634,081 | 173,485 | 143,716 | 637,050 | 21.60M |
| Balance sheet | |||||
| Cash & equivalents | $2.55M | $1.03M | $6.71M | $2.23M | — |
| Receivables | $91,689 | $108,999 | $111,066 | $74,315 | — |
| Inventory | $119,260 | $103,914 | $163,993 | $146,381 | — |
| Current assets | $5.61M | $1.78M | $7.29M | $2.72M | — |
| PP&E, net | $57,551 | $138,421 | $216,047 | $178,799 | — |
| Intangibles | $5.54M | $2.36M | $18,952 | $70,783 | — |
| Total assets | $11.37M | $4.45M | $7.95M | $3.44M | $10.76M |
| Current liabilities | $1.41M | $1.69M | $3.16M | $2.50M | — |
| Total liabilities | $1.48M | $1.83M | $3.81M | $3.81M | — |
| Shareholders' equity | $9.89M | $2.62M | $4.14M | -$367,199 | $8.44M |
| Cash flow statement | |||||
| Operating cash flow | -$1.53M | -$4.36M | -$6.41M | -$2.25M | $975,656 |
| Capital expenditure | $1,109 | $63,140 | $134,211 | $186,001 | $15,211 |
| Free cash flow | -$1.53M | -$4.42M | -$6.54M | -$2.43M | $960,445 |
| Investing cash flow | -$4.26M | -$2.44M | -$134,211 | -$186,001 | -$15,211 |
| Financing cash flow | $7.43M | $959,017 | $10.88M | -$5.80M | $9.23M |
| Depreciation & amortization | $292,284 | $172,018 | $149,078 | $94,816 | $87,094 |
| Stock-based compensation | $1.54M | $414,051 | $9.12M | — | — |
| Share buybacks | — | — | — | $6.60M | — |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.